I've checked some of my replies to you and unless you brought up "the other MSC" company, neither did I. Unlike other posters, you use the same measures when evaluating the two (mostly anyway), hence I don't see a need to point out similar incidences that are hailed as wonders one one side, and failures on the other. I think we agree that this is rather a case of "who stuffed up worse" at this stage.
Neither of the two should have seen the recent low SPs.
Sure, next 4C, I'll be here, also with a "%" update on patient recruitment in the P2 trial.
Ann: Investor Presentation, page-394
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $19.42K | 101.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8208 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 9829 | 1 |
View Market Depth
| Last trade - 15.42pm 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |